# Baseline predictors of early progression during EGFR-TKI therapy in patients with EGFR-mutant non-small cell lung cancer: A retrospective cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/baseline-predictors-of-early-progression-during-egfr-tki-therapy-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaoyan Guo,Likai Liu,Hongyan Yu,Shifeng Zhao,Chunyan Wang,Xiansheng Wang |
| Citations | 0 |
| DOI | 10.1097/md.0000000000049948 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1097/md.0000000000049948 |
| OpenAlex ID | https://openalex.org/W7171927384 |
| PMID | 42536589 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Shifeng Zhao](https://scholariq.org/researchers/shifeng-zhao/)

## Paper journal

- [Medicine](https://scholariq.org/journals/medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.